OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-GIMAP4 antibodies

Anti-GIMAP4 CAPTURE Antibody Clone OTI1C6

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA600481 Luminex validated purified GIMAP4 mouse monoclonal antibody clone (1C6, clone OTI1C6 (formerly 1C6) 100ug $325 2 Weeks
Matched Antibody
  • Luminex validated purified biotinylated GIMAP4 mouse monoclonal antibody clone (2F9), clone OTI2F9 (formerly 2F9), 50 ug
TA700481 $345 2 Weeks Add to Shopping Cart

Buy any antibody of 100ul or more, get a free package of 3 loading control antibody samples. View Details Add to Shopping Cart

spacer
LMNX(1)
spacer
Also for GIMAP4 (NM_018326)
cDNA Clone shRNA/siRNA CRISPR KO Kit Protein Antibody

OriGene Data

ImmunogenFull length human recombinant protein of human GIMAP4 (NM_0168326) produced in HEK293T cell.
Clone NameClone OTI1C6 IsotypeIgG1
Species ReactivityHuman Concentration0.5 mg/ml
Guaranteed Application *LMNX Suggested Dilutions1:100 - 1:1000
BufferStored in PBS (pH 7.4) containing 0.05% sodium azide and up to 5% trehalose

Reference Data

Target NameHomo sapiens GTPase, IMAP family member 4 (GIMAP4)
Alternative NameIAN-1; IAN1; IMAP4; MSTP062
Database LinkNP_060796
Entrez Gene 55303 Human
Function
Related Pathway

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

GIMAP4 Luminex ELISA with 1C6 Capture (TA600481) and 2F9 Detection (TA700481) Antibodies. Substrate used: Recombinant Human GIMAP4 (TP304653)
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title